3-isoxazolidone has been researched along with isoniazid in 1 studies
Studies (3-isoxazolidone) | Trials (3-isoxazolidone) | Recent Studies (post-2010) (3-isoxazolidone) | Studies (isoniazid) | Trials (isoniazid) | Recent Studies (post-2010) (isoniazid) |
---|---|---|---|---|---|
15 | 0 | 1 | 21,815 | 960 | 4,493 |
Protein | Taxonomy | 3-isoxazolidone (IC50) | isoniazid (IC50) |
---|---|---|---|
Myeloperoxidase | Homo sapiens (human) | 4.85 | |
Enoyl-[acyl-carrier-protein] reductase [NADH] | Mycobacterium tuberculosis H37Rv | 8.29 | |
Putative FAD-containing monooxygenase MymA | Mycobacterium tuberculosis H37Rv | 4.9 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gorecki, DK; Peesker, SJ; Wood, JD | 1 |
1 other study(ies) available for 3-isoxazolidone and isoniazid
Article | Year |
---|---|
3-Isoxazolidone--an inhibitor of GABA metabolism.
Topics: Aminobutyrates; Animals; Brain; Chickens; Depression, Chemical; GABA Antagonists; gamma-Aminobutyric Acid; Glutamate Decarboxylase; In Vitro Techniques; Isoniazid; Isoxazoles; Male; Mice; Oxazoles; Oxazolidinones; Rats; Seizures; Time Factors | 1976 |